|
|
Bristol-Myers Squibb Co.
|
 |
||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
|
return to message board, top of board |
Strong Buy
Re: Bristol Myers Squibb Announces TRANSCEND CLL 004 Trial of Breyanzi® (lisocabtagene ma hats off to our folks for tackling this one. the c in cll means long duration, good in that survival way better than some cancers but flip side is clinical trials more complex, take longer. do not know any of the details here but glad to see result nonetheless. |
||||||||||||
|
|
return to message board, top of board |
